Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Synergistic combinations of PI3K- and MEK-inhibitors

Synergistic combinations of PI3K- and MEK-inhibitors

US Patent 9675595 · Granted Jun 13, 2017

Estimated economic value: $14,193,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Determining device context2025
Compounds and compositions for inhibiting the activity of HIF2-alpha and their m2025
Tableware bag2022
Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhi2019
Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhi2019
Combination therapy2019
Antibodies for epidermal growth factor receptor 3 (HER3)2018
Combination of a PI3 kinase inhibitor with pacitaxel for use in the treatment or2018
Pharmaceutical diagnostic2017
MELK regulation for the treatment of breast cancer2017
Pharmaceutical combination comprising a phosphatidylinositol 3-kinase inhibitor 2017
Imidazoquinolines as dual lipid kinase and mTOR inhibitors2016